Working with TipRanks
Follow Us
Stock Ideas
Daily Updates
Calendars
Education
About Us
Working with TipRanks
Follow Us
Lexicon Pharmaceuticals (LXRX)
NASDAQ:LXRX
Lexicon Pharmaceuticals (LXRX) Stock Price & Analysis
908 Followers
LXRX Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.31 - $3.79
Previous Close$3.18
Volume6.74M
Average Volume (3M)901.98K
Market Cap
$602.81M
Enterprise Value$545.71M
Total Cash (Recent Filing)$105.94M
Total Debt (Recent Filing)$48.84M
Price to Earnings (P/E)-5.1
Beta1.83
Next Earnings
Aug 02, 2023EPS Estimate
-$0.18Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.63
Shares Outstanding189,561,819
10 Day Avg. Volume1,684,432
30 Day Avg. Volume901,980
Standard Deviation0.34
R-Squared0.04
Alpha0.02
Financial Highlights & Ratios
Price to Book (P/B)14.87
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-4.50
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue7.37K
Enterprise Value/Gross Profit3.93K
Enterprise Value/Ebitda-10.28
Forecast
1Y Price Target
$6.33Price Target Upside99.06% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering3
Lexicon Pharmaceuticals News
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Product Monthly Users
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
LXRX FAQ
What was Lexicon Pharmaceuticals’s price range in the past 12 months?
Lexicon Pharmaceuticals lowest stock price was $1.31 and its highest was $3.79 in the past 12 months.
What is Lexicon Pharmaceuticals’s market cap?
Currently, no data Available
When is Lexicon Pharmaceuticals’s upcoming earnings report date?
Lexicon Pharmaceuticals’s upcoming earnings report date is Aug 02, 2023 which is in 66 days.
How were Lexicon Pharmaceuticals’s earnings last quarter?
Lexicon Pharmaceuticals released its earnings results on May 02, 2023. The company reported -$0.17 earnings per share for the quarter, beating the consensus estimate of -$0.179 by $0.009.
Is Lexicon Pharmaceuticals overvalued?
According to Wall Street analysts Lexicon Pharmaceuticals’s price is currently Undervalued.
Does Lexicon Pharmaceuticals pay dividends?
Lexicon Pharmaceuticals does not currently pay dividends.
What is Lexicon Pharmaceuticals’s EPS estimate?
Lexicon Pharmaceuticals’s EPS estimate is -$0.18.
How many shares outstanding does Lexicon Pharmaceuticals have?
Lexicon Pharmaceuticals has 189,561,810 shares outstanding.
What happened to Lexicon Pharmaceuticals’s price movement after its last earnings report?
Lexicon Pharmaceuticals reported an EPS of -$0.17 in its last earnings report, beating expectations of -$0.179. Following the earnings report the stock price went up 15.126%.
Which hedge fund is a major shareholder of Lexicon Pharmaceuticals?
Among the largest hedge funds holding Lexicon Pharmaceuticals’s share is Fisher Asset Management LLC. It holds Lexicon Pharmaceuticals’s shares valued at 2M.
---
Lexicon Pharmaceuticals Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$6.33 (99.06% Upside)
$6.33 (99.06% Upside)
Blogger Sentiment
Bullish
LXRX Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 46.3K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days ▲ 4.3%
Last 30 Days ▲ 10.7%
Last 30 Days ▲ 10.7%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
89.28%
12-Months-Change
Fundamentals
Return on Equity
-122.16%
Trailing 12-Months
Asset Growth
19.49%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Lexicon Pharmaceuticals
Lexicon Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of pharmaceutical products for the treatment of human disease. It drug candidates include XERMELO, Sotagliflozin, LX2761, and LX9211. The company was founded by Brian P. Zambrowicz and Arthur T. Sands on July 7, 1995 and is headquartered in The Woodlands, TX.
---
Top 5 ETFs holding LXRX
iShares NASDAQ US Biotechnology UCITS ETF
$272.84K
Schwab U.S. Broad Market ETF
$162.72K
Fidelity MSCI Health Care Index ETF
$129.07K
iShares Russell 3000 ETF
$111.44K
Invesco Nasdaq Biotechnology ETF
$11.78K
Up to five ETFs with an Outperform Smart Score that hold LXRX. The ETFs are listed according to market value of LXRX within the ETF
---
Biohaven Ltd.
―
Atara Biotherapeutics
―
Nkarta
―
Scholar Rock Holding
―
C4 Therapeutics
―
---